Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -0.91%14 Earnings Yield (Joel Greenblatt) % is 188.68% as of Dec. 2025, which is 26% below its 10-year median of 255.45. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 679 Healthcare Providers & Services companies, NewGenIvf Group ranks better than 99.41% on this metric.
NewGenIvf Group's Enterprise Value for the quarter that ended in Dec. 2025 was $5.47 Mil.
NewGenIvf Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $9.52 Mil. NewGenIvf Group's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2025 was 188.68%.
The historical rank and industry rank for NewGenIvf Group's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NIVF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 158.73 Med: 255.45 Max: 343.24
Current: 161.29
During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of NewGenIvf Group was 343.24%. The lowest was 158.73%. And the median was 255.45%.
NIVF's Earnings Yield (Joel Greenblatt) % is ranked better than 99.41% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 3.73
vs NIVF: 161.29
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. NewGenIvf Group's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2025 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
NewGenIvf Group (NAS:NIVF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
NewGenIvf Group Earnings Yield (Joel Greenblatt) % Related Terms
NewGenIvf Group Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, NewGenIvf Group's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's Earnings Yield (Joel Greenblatt) % falls into.
NewGenIvf Group Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
NewGenIvf Groups Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
NewGenIvf Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.52 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 188.68% mean?
NewGenIvf Group (NIVF) has a Earnings Yield (Joel Greenblatt) % of 188.68% as of Dec. 2025. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on NewGenIvf Group and its competitors. This is 26% below median its historical median of 255.45. Over the past decade, NewGenIvf Group's Earnings Yield (Joel Greenblatt) % has ranged from 158.73 to 343.24. According to the industry distribution chart, NewGenIvf Group ranks #4 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 0.59999999999999%.
Is NewGenIvf Group's Earnings Yield (Joel Greenblatt) % too high?
NewGenIvf Group's current Earnings Yield (Joel Greenblatt) % of 188.68% is 26% below median its 10-year median of 255.45. Over the past 10 years, this metric has ranged from a low of 158.73 to a high of 343.24. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.73. NewGenIvf Group's value of 188.68% is 4958.4% above this industry median. Based on the distribution chart, NewGenIvf Group ranks #4 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Earnings Yield (Joel Greenblatt) % compare to CDIX and RHEP?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #4 out of 679 companies for Earnings Yield (Joel Greenblatt) %. This places NewGenIvf Group in the top 1% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 3.73. NewGenIvf Group's value of 188.68% is 4958.4% above this benchmark. Historically, NewGenIvf Group's own Earnings Yield (Joel Greenblatt) % has ranged from 158.73 to 343.24 over the past decade. While the company's 10-year median is 255.45 vs. the industry median of 3.73, NewGenIvf Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.73, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewGenIvf Group's current Earnings Yield (Joel Greenblatt) % of 188.68% is 4958.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on NewGenIvf Group and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current Earnings Yield (Joel Greenblatt) % is 188.68%, which is 26% below median its own 10-year median of 255.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Earnings Yield (Joel Greenblatt) % of 188.68%. The current Earnings Yield (Joel Greenblatt) % is 188.68%, which is 26% below median its 10-year median of 255.45 and 4958.4% above the Healthcare Providers & Services industry median of 3.73. NewGenIvf Group's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Earnings Yield (Joel Greenblatt) % is 188.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
